TORONTO, July 25,
2023 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX:
DHT.U) ("DRI" or "the Trust") today announced that the Trust
intends to participate in the following investor conferences in
2023:
Canaccord Genuity Annual Growth Conference
Date: August 9, 2023
Presentation time: 9:30 am ET
City: Boston, Massachusetts
Event URL:
https://www.canaccordgenuity.com/capital-markets/about-us/events/43rd-annual-growth-conference/
CIBC 22nd Annual Eastern Institutional
Conference
Date: September 28, 2023
Presentation time: TBD
City: Montreal, Quebec
Truist 2023 BioPharma Symposium
Date: November 8, 2023
Presentation time: TBD
City: New York, New York
UBS Biopharma Conference
Date: November 8-9, 2023
Presentation time: TBD
City: Miami, Florida
About DRI Healthcare
Trust
DRI Healthcare Trust is managed by DRI Capital Inc. ("DRI
Capital"), the pioneer in global pharmaceutical royalty
monetization with a more than 30-year history of accelerating
innovation by providing capital to inventors, academic institutions
and biopharma companies. Since its founding in 1989, DRI Capital
has deployed more than US$2.5
billion, acquiring more than 70 royalties on 40-plus drugs,
including Eylea, Spinraza, Zytiga, Remicade, Keytruda and Stelara.
DRI Healthcare Trust's units are listed and trade on the Toronto
Stock Exchange in Canadian dollars under the symbol "DHT.UN" and in
U.S. dollars under the symbol "DHT.U". To learn more, visit
drihealthcare.com or follow us on LinkedIn.
SOURCE DRI Healthcare Trust